Determination of ibuprofen, ketoprofen, diclofenac and phenylbutazone in bovine milk by gas chromatography-tandem mass spectrometry

Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment

Volumn 25, Issue 12, 2008, Pages 1497-1508

  Dowling, G ^a   Gallo, P ^b   Fabbrocino, S ^b   Serpe, L ^b   Regan, L ^a  

^a Backweston Laboratory Complex   (Ireland)

^b Istituto Zooprofilatico Sperimentale del Mezzogiorno   (Italy)

Author keywords

Bovine milk; Diclofenac; Ibuprofen; Ketoprofen; Method validation; Phenylbutazone

Indexed keywords

DICLOFENAC; IBUPROFEN; KETOPROFEN; PHENYLBUTAZONE;

ACCURACY; ANALYTIC METHOD; CONFERENCE PAPER; CONTROLLED STUDY; COW; DRUG DETERMINATION; DRUG MILK LEVEL; MASS FRAGMENTOGRAPHY; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; RESIDUE ANALYSIS; SOLID PHASE EXTRACTION; STANDARD; VALIDATION PROCESS;

BOVINAE;

EID: 57349187207     PISSN: 19440049     EISSN: 19440057     Source Type: Journal    
DOI: 10.1080/02652030802383160     Document Type: Article

References (30)

1. Clarke, SB, Turnipseed, SB, Nandrea, GJ, and Madson, MR. 2002. Confirmation of phenylbutazone residues in bovine kidney by liquid chromatography/mass spectrometry. J AOAC Int, 85:1009–1014.
2. Daeseleire, E, Mortier, L, De Ruyck, H, and Geerts, N. 2003. Determination of flunixin and ketoprofen in milk by liquid chromatography–tandem mass spectrometry. Anal Chim Acta, 488:25–34.
3. De Jong, EG, Kiffers, J, and Maes, RAA. 1989. The determination of non-steroidal anti-inflammatory drugs by GC-MS/MS in equine urine. J Pharm Biomed Anal, 7:1617–1622.
4. De Veau, EJI. 1999. Determination of non protein bound phenylbutazone in bovine plasma using ultra-filtration and liquid chromatography with ultraviolet detection. J Chromatogr B, 721:141–145.
5. European Commission. 1990. Council Regulation 2377/90/EEC. Off J Eur Comm. L, 224:1–8.
6. European Commission. 2002. Decision (2002/657/EC) of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and interpretation of results. Off J Eur Comm L, 221:8–36.
7. Fiori, M, Farne, M, Civitareale, C, Nasi, A, Serpe, L, and Gallo, P. 2004. The use of bovine serum albumin as a ligand in affinity chromatographic clean-up of non-steroidal anti-inflammatory drugs from bovine plasma. Chromatographia, 60:253–257.
8. Gonzalez, G, Ventura, R, Smith, AK, De la Torre, R, and Segura, J. 1996. Detection of non-steroidal anti-inflammatory drugs in equine plasma and urine by gas chromatography-mass spectrometry. J Chromatogr A, 719:251–264.
9. Goodman, A, Gilman, A, Rall, TW, Nies, AS, and Taylor, P. 1992. Goodman and Gilman's the pharmacological basis of therapeutics, Singapore:McGraw-Hill.
10. Gowik, P, Julicher, B, and Uhlig, S. 1998. Multi-Residue method for non-steroidal anti-inflammatory drugs in plasma using high performance liquid chromatography-photodiode array detector:Method description and comprehensive in-house validation. J Chromatogr B, 716:221–232.
11. Grippa, E, Santini, L, Castellano, G, Gatto, MT, Leone, MG, and Saso, L. 2000. Simultaneous determination of hydrocortisone, dexamethasone, indomethacin, phenylbutazone and oxyphenylbutazone in equine serum by high performance liquid chromatography. J Chromatogr B, 738:17–25.
12. Hardee, GE, Lai, JW, and Moore, JN. 1982. Simultaneous determination of flunixin, phenylbutazone, oxyphenylbutazone and hydroxyphenylbutazone in equine plasma by high performance liquid chromatography with application to pharmacokinetics. J Liq Chromatogr, 5:1991–2003.
13. Hines, S, Pearce, C, Bright, J, and Teale, P. 2004. Development and validation of a quantitative gas chromatography-mass spectrometry confirmatory method for phenylbutazone in equine plasma. Chromatographia, 59:S109–S114.
14. Igualada, C, and Moragues, F. 2005. Determination of phenylbutazone and oxyphenylbutazone in animal urine by ion trap liquid chromatography-mass spectrometry. Anal Chim Acta, 529:235–238.
15. International Standards. ISO/IEC 17025:1999(E). General requirements for the competence and calibration of testing laboratories, 1–25. Geneva, Switzerland:International Organization for Standardization.
16. Insel, PA. 1990. Goodman and Gilman's the pharmacological basis of therapeutics, Edited by:Goodman, A, Gilman, A, Rall, TW, Nies, AS, and Taylor, P. New York, NY:Pergamon.
17. Kari, FJ, Bucher, J, Haseman, J, Eustis, S, and Huff, H. 1995. Long-term exposure to the anti-inflammatory agent phenylbutazone induces kidney tumors in rats and liver tumors in mice. Jpn J Cancer Res, 86:252
18. Kopcha, M, Kaneene, JB, Shea, ME, Miller, R, Alwynelle, S, and Ahl, AS. 1992. Use of non-steroidal anti-inflammatory drugs in food animal practice. J Am Vet Med Assoc, 201:1868–1872.
19. Martin, K, Stridsberg, MI, and Wiese, BM. 1983. High performance liquid chromatographic method for the determination of phenylbutazone in milk with special reference to the fat content in milk. J Chromatogr, 276:224–229.
20. Miksa, IR, Cummings, MR, and Poppenga, RH. 2005. Multi-residue determination of anti-inflammatory analgesics in sera by liquid chromatography-mass spectrometry. J Anal Toxicol, 29:95–104.
21. Neto, LMR, Andraus, MH, and Salvadori, MC. 1996. Determination of phenylbutazone and oxyphenylbutazone in plasma and urine samples of horses by high performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr B, 678:211–218.
22. Quintana, MC, Ramos, L, Gonzalez, MJ, Blanco, MH, and Hernandez, L. 2004. Development of a solid phase extraction method for simultaneous determination of corticoids and tranquilizers in serum samples. J Sep Sci, 27:53–58.
23. SANCO. 2004. SANCO/2004/2726/Rev 1 Guidelines for implementation of Commission Decision 2002/657EC
24. SANCO. 2007. CRLs view on state of the art analytical methods for national residue control plans, CRL Guidance Paper (7 December 2007)
25. Singh, AK, Jang, Y, Mishra, U, and Granley, K. 1991. Simultaneous analysis of flunixin, naproxen, ethacrynic acid, indomethacin, phenylbutazone, mefenamic acid and thiosalicyclic acid in plasma and urine by high performance liquid chromatography and gas chromatography-mass spectrometry. J Chromatogr, 568:351–361.
26. Stanley, SMR, Wei, WK, Lim, BH, and Foo, HC. 2007. Direct–injection screening for acidic drugs in plasma and neutral drugs in equine urine by differential-gradient LC-LC coupled to MS/MS. J Chromatogr B, 848:292–307.
27. Taylor, MR, and Westwood, SA. 1995. Quantitiation of phenylbutazone and oxyphenylbutazone in equine plasma by high performance liquid chromatography with solid-phase extraction. J Chromatogr A, 697:389–396.
28. US Code of Federal Regulations. 1988. 21 pts 520.1720 and 522.1720
29. Van Hoof, N, De Wasch, K, Poelmans, S, Noppe, H, and De Brabander, H. 2004. Multi-residue liquid chromatography tandem mass spectrometry method for the detection of non-steroidal anti-inflammatory drugs in bovine muscle; optimization of ion trap parameters. Rapid Commun Mass Spectrom, 18:2823–2829.
30. Vinci, F, Fabbrocino, S, Fiori, M, Serpe, L, and Gallo, P. 2006. Determination of fourteen non-steroidal anti-inflammatory drugs in animal serum and plasma by liquid chromatography/ mass spectrometry. Rapid Comm Mass Spectrom, 20:3412–3420.